Table 7. Cox models for death and death or intubation by type of glucocorticoid therapy.

	Death				Death or intubation
	Whole cohort		SpO2/FiO2 ≤353		Whole cohort		SpO2/FiO2 ≤353
	HR (95%CI)*	p	HR (95%CI)*	p	HR (95%CI)**	p	HR (95%CI)**	p
Week-2-MP	reference		reference		reference		reference
Non-pulse glucocorticoids	10.09 (2.14–47.50)	0.003	16.20 (1.86–141.05)	0.012	13.71 (3.76–50.07)	<0.001	15.50 (3.14–76.38)	0.001
Out-of-week-2-MP	5.04 (0.91–27.86)	0.064	9.83 (0.78–12.41)	0.044	7.38 (1.86–29.29)	0.004	9.72 (1.91–49.31)	0.006
No glucocorticoids	4.14 (0.81–21.23)	0.088	7.04 (0.78–63.71)	0.082	3.58 (0.89–14.32)	0.072	5.07 (1.00–25.67)	0.050

MP: methyl-prednisolone pulses; Week-2-MP: methyl-prednisolone pulses in week 2. HR: hazard ratio; CI: confidence interval.

*Model adjusted by hypertension, SaO2FiO2 and Curb65 score.

**Model adjusted by SaO2FiO2 and Curb65 score.